Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma

doi:10.3748/wjg.v30.i6.565

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3557)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series.

Item

Count

PDF

133

WORD

HTML

1779

Figures (1-8)

218

Sum=2142

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

263

Download

394

Sum=657

Publishing Process of This Article

Item

Count

Browse

145

Download

500

Sum=645

Feb 14, 2024 (publication date) through Jan 18, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 14, 2024; 30(6): 565-578
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565

Full Size Figure Download Figure

Figure 6 JOSD2 promotes in vivo esophageal squamous cell carcinoma cell proliferation and cisplatin resistance. A and B: JOSD2-knockdown cisplatin-treated KYSE150 cells exhibited significantly decreased tumor growth in both volume (A) and weight (B) compared to cisplatin-treated control cells; C and D: JOSD2-overexpressing cisplatin-treated KYSE30 cells exhibited significantly increased tumor growth in both volume (C) and weight (D) compared to cisplatin-treated control cells. ^bP < 0.001; ^cP < 0.0001.

Citation: Wang WP, Shi D, Yun D, Hu J, Wang JF, Liu J, Yang YP, Li MR, Wang JF, Kong DL. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma. World J Gastroenterol 2024; 30(6): 565-578
URL: https://www.wjgnet.com/1007-9327/full/v30/i6/565.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i6.565